Shiprock, NMNCT06525259Now EnrollingIRB Ready

Diabetes Mellitus Type 2, Childhood-Onset Clinical Trial in Shiprock, NM

Access cutting-edge diabetes mellitus type 2, childhood-onset treatment through this clinical trial at a research site in Shiprock. Study-provided care at no cost to qualified participants.

Sponsored by George Washington University

Quick Self-Assessment

See if you qualify for this Shiprock location

Preparing your pre-screening questions…

Expert Care in Shiprock

Access diabetes mellitus type 2, childhood-onset specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related diabetes mellitus type 2, childhood-onset treatment provided free

Apply for This Shiprock Location

Check if you qualify for this diabetes mellitus type 2, childhood-onset clinical trial in Shiprock, NM

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Shiprock

    Convenient for NM residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Shiprock site if eligible
  4. 4Begin participation

About This Diabetes Mellitus Type 2, Childhood-Onset Study in Shiprock

The goal of the DISCOVERY study is to provide innovative critical information regarding the unique natural history of glycemic control, insulin sensitivity, and β-cell function, and their mechanistic determinates, in obese adolescents at risk for developing type 2 diabetes.

Sponsor: George Washington University

Who Can Participate

Inclusion Criteria

Screening will occur to enrich the yield of individuals who are highly predisposed to develop youth-onset T2D and include those with all of the following criteria:
Overweight or obesity with BMI ≥85th percentile
Age 8-13 year for girls, 9-15 year for boys (inclusion younger for girls as puberty tends to start a year earlier in girls)
Tanner Stage 2, 3, or 4
Elevated HbA1c 5.5-6.4%

Exclusion Criteria

An individual who meets any of the following criteria will be excluded from participation:
Diabetes based on history, or HbA1c ≥6.5% in the medical record or at screening
Unable/unwilling to provide consent/participate fully
Conditions predisposing to diabetes or altering the trajectory of puberty
Medications affecting glucose dynamics during the screening and enrollment period
Prior treatment with insulin
Use of glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications in the 6 weeks prior to enrollment
Planning treatment with glucagon-like peptide-1 (GLP-1) receptor agonist or any weight loss medications
Use of metformin or any glucose lowering medication for a reason other than treatment of diabetes (e.g., for PCOS) in the 6 weeks prior to enrollment
Planning treatment with metformin or any glucose lowering medication or planning to use such medications for a reason other than treatment of diabetes (e.g., for PCOS)
Known syndromic/monogenic obesity
Blood disorders impacting HbA1c (e.g., anemia, hemoglobin variants)
Major systemic organ disease
History of bariatric surgery or currently planning bariatric surgery
Current pregnancy or currently planning pregnancy
Use of GnRH agonist, estrogen, or testosterone
Individuals who do not speak English or Spanish, given validation of the questionnaires to be utilized

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Shiprock?

Yes, this clinical trial (NCT06525259) has an active research site in Shiprock, NM that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Diabetes Mellitus Type 2, Childhood-Onset Treatment Options in Shiprock, NM

If you're searching for diabetes mellitus type 2, childhood-onset treatment options in Shiprock, NM, this clinical trial (NCT06525259) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Shiprock research site is actively enrolling participants for this clinical trial. You'll receive care from experienced diabetes mellitus type 2, childhood-onset specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all diabetes mellitus type 2, childhood-onset clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Shiprock, NM

See all pulmonary embolism clinical trials recruiting in Shiprock — not just this study.

Browse Pulmonary Embolism Trials in Shiprock →

Browse More Trials by Condition

Pulmonary Embolism TrialsEssential Tremor TrialsType 2 Diabetes TrialsInterstitial Lung Disease TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Shiprock?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Shiprock, NM